Author
- 1
liu, w.-s. and chan, h.-l. and lai, y.-t. and yang, y.-h. and teng, h.-w. and liu, c.-k. and li, s.-y. and yang, c.-y. and liu, t.-y. and lin, c.-c.
- 1
liu, w.-s., chan, h.-l., yang, y.-h., teng, h.-w., liu, c.-k., li, s.-y., yang, c.-y., liu, t.-y., lin, c.-c.
- 1
yen-ting lai
Refined By:
Subject:
aluminum; c reactive protein; calcium; cholesterol; continuous erythropoiesis receptor activator; creatinine; lactate dehydrogenase; novel erythropoiesis stimulating protein; parathyroid hormone; phosphate; potassium; aluminum; antianemic agent; cholesterol; continuous erythropoiesis receptor activator; creatinine; erythropoietin; macrogol derivative; novel erythropoiesis stimulating protein; parathyroid hormone; aged; aluminum blood level; article; controlled study; drug substitution; drug withdrawal; end stage renal disease; erythrocyte; erythropoiesis; female; hematocrit; hemodialysis; human; inflammation; major clinical study; male; observational study; outcome assessment; priority journal; taiwan; thrombocyte count; uremia; blood; erythrocyte count; hemodialysis; middle aged; uremia; very elderly; aged; aged, 80 and over; aluminum; cholesterol; creatinine; darbepoetin alfa; erythrocyte count; erythropoietin; female; hematinics; humans; male; middle aged; parathyroid hormone; platelet count; polyethylene glycols; renal dialysis; uremia
Results 1-1 of 1 (Search time: 0.009 seconds).
| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
1 | 2016 | Shift from darbepoetin-α to continuous erythropoietin receptor activator decreases serum aluminium concentration in patients on hemodialysis | Yen-Ting Lai ; Liu, W.-S., Chan, H.-L., Yang, Y.-H., Teng, H.-W., Liu, C.-K., Li, S.-Y., Yang, C.-Y., Liu, T.-Y., Lin, C.-C. | Environmental Toxicology and Pharmacology | 3 | 3 | |